克罗恩病作为泛淋巴功能障碍的肠道表现:基于基本和临床数据的探索性建议
Yu-Wei Zhou1, Yue Ren2, Miao-Miao Lu3
1Department of Gastroenterology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang Province, China.
World journal of gastroenterology
|January 31, 2024
概括
克罗恩病可能源于广泛的淋巴功能障碍,影响免疫细胞和肠道新陈代谢. 本综述提出了一种针对淋巴功能的新型治疗方法,可能有利于不响应的患者.
科学领域:
- 胃肠道学和免疫学
- 淋巴系统生物学 淋巴系统生物学
- 疾病病因学和治疗方法
背景情况:
- 克罗恩氏病 (CD) 的患病率正在上升,但其原因仍然不清楚,许多患者对当前的治疗没有反应.
- 现有的CD疗法,包括生物和小分子药物,在很大一部分患者中显示出有限的疗效.
- 迫切需要创新的治疗策略来解决克罗恩病的复杂性.
研究的目的:
- 提出一种全淋巴功能障碍的新概念,作为CD病因学的统一理论.
- 提出初步数据支持CD作为泛淋巴功能障碍的肠道表现.
- 突出针对淋巴功能新型CD疗法的潜力.
主要方法:
- 对CD中淋巴系统功能的现有基本和临床数据的审查和综合.
- 探索"内外"模型及其与CD中免疫细胞疾病和细胞可塑性的相关性.
- 评估CD和其他与淋巴功能障碍相关的疾病之间的肠道脂肪和胆酸代谢的共同点.
主要成果:
- 有证据表明,在CD中存在淋巴系统功能障碍,涉及免疫细胞疾病和细胞可塑性的改变.
- "内外"模型为了解与淋巴问题相关的CD病变发生提供了一个框架.
- 共同的机制,包括肠道衍生的脂肪和胆酸代谢,将CD与更广泛的淋巴功能障碍联系起来.
结论:
- 克罗恩病可以理解为一种更广泛的疾病的肠道表现,称为泛淋巴功能障碍.
- 斑马鱼模型为研究CD等肠道疾病提供了有价值的工具,特别是淋巴功能障碍.
- 专注于改善淋巴功能,为开发克罗恩病的新有效疗法提供了一个有希望的途径.
相关概念视频
01:30Inflammatory Bowel Disease II: Crohn's Disease
244
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
244
01:17Chronic Bowel Disorders: Introduction
450
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
450
01:24Chronic Pancreatitis I: Introduction
89
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
89
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
186
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
186
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
334
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
334
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
137
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
137